Food and Drug Administration Approves Breakthrough Gene Therapy Treatment for Rare Pediatric Genetic Disorders
The Food and Drug Administration granted commercial authorization for an advanced one-time gene therapy treatment developed for children suffering from debilitating hereditary metabolic disorders, offering new therapeutic options evaluated under expedited regulatory review pathways.